Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Lifecore Biomedical, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 90 | 86 | −4 |
| Shares | 25.3M | 24.7M | −536.5K (−2.1%) |
| Value | $252.1M | $220.0M | −$32.1M (−12.7%) |
New holders (3)
Institutions that held Lifecore Biomedical, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 15,410 | $137.0K | 0.02% |
| Mirae Asset Global Investments Co., Ltd. | 10,860 | $97.0K | 0.00% |
| Aquatic Capital Management LLC | 2,400 | $21.0K | 0.00% |
Sold out (7)
Institutions that held Lifecore Biomedical, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Employees Retirement System of Texas | 170,400 | $1.70M |
| Jacobs Levy Equity Management, Inc | 28,549 | $285.0K |
| State of Tennessee, Treasury Department | 24,576 | $245.0K |
| AQR Capital Management LLC | 21,782 | $217.0K |
| PEAK6 Investments LLC | 18,524 | $179.1K |
| Citadel Advisors LLC | 17,539 | $175.0K |
| Public Employees Retirement System of Ohio | 1,896 | $19.0K |